新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
10期
671-674
,共4页
双水平气道正压无创通气%急性心源性肺水肿
雙水平氣道正壓無創通氣%急性心源性肺水腫
쌍수평기도정압무창통기%급성심원성폐수종
BiPAP non-invasive ventilation%Acute cardiogenic pulmonary edema
目的:观察双水平气道正压(BiPAP)无创通气治疗急性心源性肺水肿患者的临床疗效。方法收集85例急性心源性肺水肿患者的治疗情况,其中给予正性肌力药物、利尿药、血管活性药物等常规抗心力衰竭治疗的基础上行 BiPAP 无创通气治疗的50例患者作为治疗组,给予面罩吸氧等常规抗心力衰竭治疗的35例患者为对照组。比较两组的临床疗效。结果与对照组比较,治疗组患者经 BiPAP 无创通气治疗后,患者的临床症状改善更明显,6 h 乳酸清除率及治疗有效率均明显高于对照组(P 均<0.05),气管插管率及病死率均明显低于对照组(P 均<0.05)。结论BiPAP 无创通气能迅速改善急性心源性肺水肿患者的临床症状,降低气管插管率及病死率。
目的:觀察雙水平氣道正壓(BiPAP)無創通氣治療急性心源性肺水腫患者的臨床療效。方法收集85例急性心源性肺水腫患者的治療情況,其中給予正性肌力藥物、利尿藥、血管活性藥物等常規抗心力衰竭治療的基礎上行 BiPAP 無創通氣治療的50例患者作為治療組,給予麵罩吸氧等常規抗心力衰竭治療的35例患者為對照組。比較兩組的臨床療效。結果與對照組比較,治療組患者經 BiPAP 無創通氣治療後,患者的臨床癥狀改善更明顯,6 h 乳痠清除率及治療有效率均明顯高于對照組(P 均<0.05),氣管插管率及病死率均明顯低于對照組(P 均<0.05)。結論BiPAP 無創通氣能迅速改善急性心源性肺水腫患者的臨床癥狀,降低氣管插管率及病死率。
목적:관찰쌍수평기도정압(BiPAP)무창통기치료급성심원성폐수종환자적림상료효。방법수집85례급성심원성폐수종환자적치료정황,기중급여정성기력약물、이뇨약、혈관활성약물등상규항심력쇠갈치료적기출상행 BiPAP 무창통기치료적50례환자작위치료조,급여면조흡양등상규항심력쇠갈치료적35례환자위대조조。비교량조적림상료효。결과여대조조비교,치료조환자경 BiPAP 무창통기치료후,환자적림상증상개선경명현,6 h 유산청제솔급치료유효솔균명현고우대조조(P 균<0.05),기관삽관솔급병사솔균명현저우대조조(P 균<0.05)。결론BiPAP 무창통기능신속개선급성심원성폐수종환자적림상증상,강저기관삽관솔급병사솔。
Objective To observe the clinical efficacy of non-invasive bi-level positive airway pres-sure ventilation (BiPAP)in the treatment of patients with acute cardiogenic pulmonary edema.Methods Eighty-five patients with acute cardiogenic pulmonary edema were retrospectively analyzed and assigned into two groups.In the treatment group,fifty cases were treated with BiPAP non-invasive ventilation on the basis of anti-heart failure treatment such as positive inotropic,diuretics and vasoactive drugs.In the control group,35 pa-tients underwent oxygen masks based upon anti-heart failure therapy.The clinical effects in two groups were compared.Results Compared with the control group,the clinical symptoms of the patients,who treated with BiPAP non-invasive ventilation,were significantly improved,and 6-hour lactic acid clearance rate and effective rate were significantly higher (all P <0.05),whereas endotracheal intubation rate and mortality were signifi-cantly lower (both P <0.05).Conclusion BiPAP can alleviate the symptoms of patients with acute cardio-genic pulmonary edema and reduce endotracheal intubation rate and mortality.